Evaluation of clinicopathological factors in PD-1 response: derivation and validation of a prediction scale for response to PD-1 monotherapy-Reference-Cited by-同舟云学术

Evaluation of clinicopathological factors in PD-1 response: derivation and validation of a prediction scale for response to PD-1 monotherapy

Published:2017-03-21 Issue:9 Volume:116 Page:1141-1147
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Nosrati Adi,Tsai Katy K,Goldinger Simone M,Tumeh Paul,Grimes Barbara,Loo Kimberly,Algazi Alain P,Nguyen-Kim Thi Dan Linh,Levesque Mitchell,Dummer Reinhard,Hamid Omid,Daud Adil

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/bjc201770.pdf

Reference34 articles.

1. Blank C, Brown I, Peterson AC, Spiotto M, Iwai Y, Honjo T, Gajewski TF (2004) PD-L1/B7H-1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8+ T cells. Cancer Res 64: 1140–1145.

2. Blank CU, Haanen JB, Ribas A, Schumacher TN (2016) Cancer immunology. The ‘cancer immunogram’. Science 352: 658–660.

3. Brahmer JR, Drake CG, Wollner I, Powderly JD, Picus J, Sharfman WH, Stankevich E, Pons A, Salay TM, Mcmiller TL, Gilson MM, Wang C, Selby M, Taube JM, Anders R, Chen L, Korman AJ, Pardoll DM, Lowy I, Topalian SL (2010) Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates. J Clin Oncol 28: 3167–3175.

4. Daud AI, Loo K, Pauli ML, Sanchez-Rodriguez R, Sandoval PM, Taravati K, Tsai K, Nosrati A, Nardo L, Alvarado MD, Algazi AP, Pampaloni MH, Lobach IV, Hwang J, Pierce RH, Gratz IK, Krummel MF, Rosenblum MD (2016) Tumor immune profiling predicts response to anti-PD-1 therapy in human melanoma. J Clin Invest 126: 3447–3452.

5. Deeks ED (2016) Pembrolizumab: a review in advanced melanoma. Drugs 76: 375–386.

Cited by 125 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigating the correlation between PD-L1 expression and radiomics predictions in non-small cell lung cancer using PET/CT imaging analysis;2024-04-08

2. Immune checkpoint inhibitors in metastatic melanoma therapy (Review);Medicine International;2024-02-09

3. A prediction model for response to immune checkpoint inhibition in advanced melanoma;International Journal of Cancer;2024-01-31

4. Clinical factors associated with the therapeutic efficacy of atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma: A multicenter prospective observational study;PLOS ONE;2024-01-02

5. PTPRC functions as a prognosis biomarker in the tumor microenvironment of cutaneous melanoma;Scientific Reports;2023-11-23